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In quiescent rat thyroid (FRTL-5) cells, phorbol-l2-myristate-l3-acetate (PMA) inhibited DNA synthesis induced by 
a combination of insulin and thyrotropin (TSH) or dibutyryl cyclic AMP (B\cAMP). This inhibitory effect of PMA 
was observed even when PMA was added after addition of these growth factors, and was maximal when PMA was added 
24 h after the growth factors (late in the t&-phase of the cell cycle). On the other hand, PMA alone induced DNA synthe- 
sis and also enhanced that induced by BGcAMP or insulin in these quiescent cells. I-Oleoyl-2-acetylglycerol mimicked 
these effects of PMA, but 4a-phorbol-12,13-didecanoate had no effect. These data demonstrate that in FRTL-5 ‘cells 
protein kinase C has a stimulatory effect on the G, to G, transition and an inhibitory effect on the G, to S transition 
in the cell cycle. 
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1. INTRODUCTION 
It is of great interest to study the control 
mechanisms of proliferation in FRTL-5 cells as an 
in vitro model of goitrous thyroid diseases. In 
human, rat and dog thyroid cells, TSH is a potent 
growth factor [l-3]. However, recently in human 
and rat thyroid, TSH was found to stimulate not 
only CAMP synthesis but also PIP2 hydrolysis with 
the generation of IP3 and DAG [4-61. 
Protein kinase C, an enzyme that is activated by 
DAG or phorbol esters in the presence of Ca2+ and 
phospholipid, plays important roles in transmem- 
brane signaling [7]. 
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The following materials were used: [mefhyl-3H]thymidine 
(DuPont); PMA and 4~PDD (LC Services Co.); OAG (Ser- 
dary Res. Lab.); TSH, BtzcAMP, insulin and 3-isobutyl-l- 
methylxanthine (Sigma); CAMP RIA kits (Yamasu Shoyu Co.). 
Other materials and chemicals were obtained from commercial 
sources. 
2.2. Cell culture and assay for DNA synthesis 
Abbreviations: PMA, phorbol-12.myristate-13-acetate; TSH, 
thyrotropin; BtlcAMP, dibutyryl cyclic AMP; OAG, l-oleoyl- 
FRTL-5 cells were seeded into 24-well costar trays (approx. 
2 x IO5 cells/well) in Coon’s modified Ham F-12 medium con- 
2-acetylglycerol; 4cu-PDD, 4ry-phorbol-12,13-didecanoate; taining 5% calf serum, TSH (10’ /U/ml), transferrin 
PIP& phosphatidylinositol 4,5-bisphosphate; IPI, inositol (5 pg/ml), insulin (10 pg/ml), somatostatin (IO ng/ml), cor- 
1,4,5_trisphosphate; DAG, diacylglycerol; PDGF, platelet- tisone (10 nM) and the tripeptide glycyl-L-histidyl-L-lysine 
derived growth factor acetate (10 ng/ml) as described previously [12], and were in- 
Although phorbol esters have been known for 
many years to stimulate cell proliferation in 
various cell types, some examples of their growth 
inhibition have been reported [8-l 11. 
In this paper, we show that protein kinase C ac- 
tivated by phorbol esters can exert both 
stimulatory and inhibitory effects that may be 
related to different phases in the cell cycle. 
2. MATERIALS AND METHODS 
2.1. Materials 
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cubated at 37°C in a humidified atmosphere (95% air, 5% COZ) 
for at least one week. The culture medium was changed twice 
weekly. 
For measurement of DNA synthesis, the cells were washed 
twice with PBS( - ) and then incubated in RPMI-1640 contain- 
ing 0.1% BSA and 0.1% DMSO for 48 h. They were then in- 
cubated for 48 h in RPM1 containing 0.1% BSA, 0.1% DMSO, 
transferrin (5 pg/ml) and [mefhy/-3H]thymidine (0.5 &i/well) 
and with or without one or more of the following compounds: 
insulin (10 pg/ml), TSH (102pU/ml), BtzcAMP (0.1 mM) and 
PMA (lo-’ M). PMA also was added to the wells at different 
times before and after addition of other compounds. 
The reaction was stopped by addition of 10% trichloroacetic 
acid and the radioactivity in acid-insoluble materials was 
counted in a liquid scintillation spectrometer. 
3. RESULTS 
Addition of PMA to quiescent FRTL-5 cells 
slightly enhanced DNA synthesis induced by in- 
sulin, but markedly inhibited that induced by a 
combination of TSH and insulin (fig.1). Addition 
of PMA at different times before and after addi- 
tion of the growth factors showed that it inhibited 
DNA synthesis even when added after TSH and in- 
sulin, its effect being maximal when it was added 
2-4 h after their addition (late in the Gr phase of 
the cell cycle). 
Most effects of TSH on the thyroid are mediated 
through activation of the adenylate cyclase-cyclic 
AMP system. We investigated whether adenylate 
Fig. 1. Stimulation and inhibition of DNA synthesis by PMA in 
FRTL-5 cells. PMA (IO-’ M) was added to the cells at the 
indicated times relative to the addition of insulin only or with 
TSH. +2 h represents addition of PMA 2 h after the growth 
factors and so +48 h represents no addition of PMA. (0) 
DNA synthesis in the presence of insulin (10 /g/ml); (0) DNA 
synthesis in the presence of TSH (lOZ~U/ml) and insulin 
(10 pg/ml). Points and bars indicate means of- SD for triplicate 
determinations. 
Time (h) 
Fig.2. Effect of PMA pretreatment on TSH-induced CAMP 
accumulation in FRTL-5 cells during 2 h incubation. PMA 
(lo-’ M) was added to the wells at the indicated times relative 
to the addition of TSH (IO2 gU/ml). -2 h represents 2 h 
preincubation with PMA and so + 2 h represents no addition of 
PMA. Points and bars indicate means + SD for triplicate 
determinations. 
cyclase in FRTL-5 cells was modulated by pretreat- 
ment of the cells with PMA for various periods. 
Results showed that PMA pretreatment inhibited 
the TSH-induced CAMP response, inhibition being 
maximal with a pretreatment period of 4-6 h 
(fig.2). 
We next examined whether the inhibitory effect 
of PMA on DNA synthesis resulted from inhibi- 
tion of TSH-induced CAMP accumulation. PMA 
inhibited DNA synthesis induced by a combination 
of BtzcAMP and insulin, and the inhibition was 
greatest when PMA was added after addition of 
the growth factors (fig.3). 
PMA alone induced DNA synthesis and also did 
not inhibit that induced by Bt2cAMP (table 1). 
OAG mimicked these dual effects of PMA on 
DNA synthesis, but ~CX-PDD was ineffective (not 
shown). Moreover, in cells in which the level of 
T,me (h) 
Fig.3. Inhibition by PMA of DNA synthesis induced by 
BtzcAMP (0.1 mM) plus insulin (lOpg/ml). Times of addition 
of PMA are represented as described for fig. 1. Points and bars 
indicate means + SD for triplicate determinations. 
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Table 1 
Effect of PMA on DNA synthesis 
Additions [3H]Thymidine incorporation 
(cpm x 10d4 /well) 
Without PMA With PMA 
(IO-’ M) 
None 0.96 + 0.07 2.01 i 0.18 
BtzcAMP (0.1 mM) 3.58 + p.13 4.13 If- 0.41 
Insulin (10 /g/ml) 1.09 -t 0.07 3.27 f 0.37 
BtzcAMP + insulin 5.10 * 0.07 4.26 + 0.13 
DNA synthesis was assayed in the presence of the indicated 
additions. Values are means -+ SD for triplicate determinations 
protein kinase C was reduced by 48 h pretreatment 
with 10m6 M PMA, PMA showed no stimulatory 
or inhibitory effect on DNA synthesis induced by 
one or more growth factors (table 2). 
4. DISCUSSION 
In this work we found that PMA had both 
stimulatory and inhibitory effects on DNA syn- 
thesis in FRTL-5 cells depending on the presence 
of other growth factors. It is known that PMA and 
OAG activate protein kinase C, whereas 4a-PDD 
does not. Since these effects of PMA on DNA syn- 
thesis were mimicked by OAG but not by 4cu-PDD, 
and were abolished by down regulation of protein 
kinase C, we conclude that they are mediated 
through the activation of protein kinase C. 
Pretreatment of the cells with PMA decreased 
Table 2 
Effect of down-regulation of protein kinase C on DNA 
synthesis 
Additions [‘HlThymidine incorporation 
(cpm x IO-“/well) 
Without PMA With PMA 
(lo-’ M) 
Insulin (10 @g/ml) 1.16 f 0.09 1.15 + 0.01 
Insulin + TSH 
(lO’~U/ml) 7.58 t 0.14 7.36 f 0.02 
Insulin + BtzcAMP 
(0.1 mM) 5.07 f 0.23 4.81 t 0.20 
Cells were depleted of protein kinase C by pretreatment with 
10mh M PMA for 48 h. Then their DNA synthesis was assayed 
in the presence of the indicated additions. Values are means 2 
SD for triplicate determinations 
TSH-induced CAMP accumulation. In the late Gr 
phase of the cell cycle PMA also inhibited DNA 
synthesis induced by a combination of TSH and in- 
sulin. However, since PMA also inhibited DNA 
synthesis induced by a combination of BtzcAMP 
and insulin in the late Gr phase, it probably has 
another mechanism for the inhibition of DNA syn- 
thesis besides that of inhibiting the TSH-induced 
CAMP response. 
There are reports of growth inhibition by phor- 
bol esters [8-l 11. In rat vascular smooth muscle, 
PMA was recently shown to inhibit thrombin- 
induced inositol trisphosphate release and DNA 
synthesis induced by thrombin at the Gr to S tran- 
sition, but not DNA synthesis induced by platelet- 
derived growth factor (PDGF) [lo]. Moreover, 
rabbit aortic smooth muscle cells are sensitive to 
both the stimulatory and the inhibitory actions of 
protein kinase C, depending on the presence of the 
other growth factors in the regulation of prolifera- 
tion [ll]. 
In FRTL-5 cells, PMA alone induced DNA syn- 
thesis and also enhanced that induced by insulin or 
BtzcAMP. Conceivably PMA stimulates DNA syn- 
thesis at the Go to Gr transition in the cell cycle, 
since it inhibits the Gr to S transition in FRTL-5 
cells. Thus our results demonstrate that protein 
kinase C has dual effects on two well-defined tran- 
sition points in the cell cycle, namely the Go to Gr 
transition and the Gr to S transition in FRTL-5 
cells. 
Inhibition of growth is important in the develop- 
ment of normal tissues and in tumor formation 
[ 131. Therefore, the dual action of protein kinase 
C at two transition points of FRTL-5 cells is very 
important for the fine regulation of the complex 
system involved in cell proliferation. 
Protein kinase C has both positive and negative 
actions that depend on the function of the target 
substrate protein, in which it phosphorylates the 
seryl and threonyl residues [7]. The protein 
product of the ras proto-oncogene is known to be 
required for initiation of the S phase of the cell 
cycle in response to stimulation by serum [14]. In 
addition, the product of the Harvery ras oncogene, 
~21, is a substrate for protein kinase C in vitro 
[15]. The inhibitory action of protein kinase C at 
the Gr to S transition in the cell cycle may possibly 
be due to its phosphorylation of the ras proto- 
oncogene product. 
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But the mechanisms by which protein kinase C 
modulates cell proliferation positively and 
negatively remain to be clarified. 
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